Cargando…

Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study

INTRODUCTION: Mammographic density (MD) is a strong biomarker of breast cancer risk. MD increases after women start estrogen plus progestin therapy (EPT) and decreases after women quit EPT. A large interindividual variation in EPT-associated MD change has been observed, but few studies have investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Eunjung, Luo, Jianning, Su, Yu-Chen, Lewinger, Juan Pablo, Schumacher, Fredrick R, Van Den Berg, David, Wu, Anna H, Bernstein, Leslie, Ursin, Giske
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318222/ https://www.ncbi.nlm.nih.gov/pubmed/25499601 http://dx.doi.org/10.1186/s13058-014-0477-8

Ejemplares similares

Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California Teachers Study
por: Lee, Eunjung, et al.
Publicado: (2018)

The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort
por: Lee, Eunjung, et al.
Publicado: (2011)

Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study
por: Crandall, Carolyn, et al.
Publicado: (2005)

Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users
por: Ellingjord-Dale, Merete, et al.
Publicado: (2012)

Genetic determinants of mammographic density
por: Haiman, Christopher A, et al.
Publicado: (2002)

Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort
por: Marshall, Sarah F, et al.
Publicado: (2010)

Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study
por: Lord, Sarah J, et al.
Publicado: (2005)

Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case–control and a case–case comparison
por: Ma, Huiyan, et al.
Publicado: (2006)

Alcohol consumption, endogenous estrogen and mammographic density among premenopausal women
por: Frydenberg, Hanne, et al.
Publicado: (2015)

Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women
por: Iversen, Anita, et al.
Publicado: (2016)

Mammographic screening debate on study design: a need to move the field forward
por: Ursin, Giske
Publicado: (2012)

Hormonal determinants of mammographic density and density change
por: Gabrielson, Marike, et al.
Publicado: (2020)

Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort
por: Largent, Joan A., et al.
Publicado: (2010)

Variation in Inflammatory Cytokine/Growth-Factor Genes and Mammographic Density in Premenopausal Women Aged 50–55
por: Ozhand, Ali, et al.
Publicado: (2013)

Is there a positive association between mammographic density and bone mineral density? Authors' response
por: Crandall, Carolyn, et al.
Publicado: (2006)

Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study
por: Bremnes, Yngve, et al.
Publicado: (2007)

Menopausal Hormone Therapy and Lung Cancer-Specific Mortality Following Diagnosis: The California Teachers Study
por: Clague, Jessica, et al.
Publicado: (2014)

Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies
por: Ma, Huiyan, et al.
Publicado: (2006)

Mammographic density and inter-observer variability of pathologic evaluation of core biopsies among women with mammographic abnormalities
por: Trocchi, Pietro, et al.
Publicado: (2012)

Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer
por: Gram, Inger T, et al.
Publicado: (2005)

Serum Levels of Commonly Detected Persistent Organic Pollutants and Per- and Polyfluoroalkyl Substances (PFASs) and Mammographic Density in Postmenopausal Women
por: Lee, Eunjung, et al.
Publicado: (2020)

The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors
por: Aupperlee, Mark D., et al.
Publicado: (2018)

Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes.
por: Fjeldheim, F. N., et al.
Publicado: (2016)

Hormone replacement therapy, percent mammographic density and the sensitivity of mammography
por: Kavanagh, AM, et al.
Publicado: (2004)

Physical activity and mammographic density in a cohort of postmenopausal Norwegian women; a cross-sectional study
por: Qureshi, Samera Azeem, et al.
Publicado: (2012)

Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort
por: Ma, Huiyan, et al.
Publicado: (2010)

Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk
por: Hudson, Sue, et al.
Publicado: (2018)

Mammographic density and histopathologic characteristics of screen-detected tumors in the Norwegian Breast Cancer Screening Program
por: Moshina, Nataliia, et al.
Publicado: (2015)

Lifetime body size and estrogen-receptor-positive breast cancer risk in the California Teachers Study cohort
por: Horn-Ross, Pamela L., et al.
Publicado: (2016)

Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study
por: Stuedal, Anne, et al.
Publicado: (2006)

Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study
por: Hoffman, Sarah R., et al.
Publicado: (2023)

Hormone replacement therapy and mammographic density: a systematic literature review
por: Azam, Shadi, et al.
Publicado: (2020)

Greatly increased occurrence of breast cancers in areas of mammographically dense tissue
por: Ursin, Giske, et al.
Publicado: (2005)

Does a polymorphism in the CYP17 gene predict mammographic density?
por: Ursin, G, et al.
Publicado: (2000)

An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005)

Postmenopausal estrogen and progestin effects on the serum proteome
por: Pitteri, Sharon J, et al.
Publicado: (2009)

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density
por: Rudolph, Anja, et al.
Publicado: (2015)

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Polymorphisms in genes involved in the estrogen pathway and mammographic density
por: Dumas, Isabelle, et al.
Publicado: (2010)

The association of age at menarche and adult height with mammographic density in the International Consortium of Mammographic Density
por: Ward, Sarah V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_upg3tbgje5sqaqtgibt4847v7p